# Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/inspection-of-injectable-products-for-visible-particulates-draft-guidance-for-industry/3db61da7-cb07-4d7e-b933-ef2ea35c7c1c

> FDA guidance document: Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry. Issue date: December 16, 2021. Get complete insights and analysis.

---

## Details

- Title: Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2021-12-16
- Comment Close Date: 2022-02-15
- Last Changed: 2021-12-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-D-0241">FDA-2021-D-0241</a>

## Related Documents

- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)
- [Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities](https://www.globalkeysolutions.net/guidances/guidance-document/remote-interactive-evaluations-of-drug-manufacturing-and-bioresearch-monitoring-facilities/b3f969a3-6d17-4b51-aee6-e6cb19f8e4ba)
- [Postapproval Changes to Drug Substances Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/postapproval-changes-to-drug-substances-guidance-for-industry/78d470cd-b4c0-45be-b582-1163b9b97017)